PILOT
831175
XINGANJIANG
873167
Beijing Highlander Digital Technology
300065
4
Hangzhou Gaoxin Materials Technology
300478
5
Shijihengtong Technology
301428
US Stock MarketDetailed Quotes
RCEL Avita Medical
- 10.570
- +1.790+20.39%
Close Feb 14 16:00 ET
- 10.400
- -0.170-1.61%
Post 20:01 ET
278.60MMarket Cap-4.42P/E (TTM)
11.250High9.700Low952.30KVolume9.920Open8.780Pre Close10.04MTurnover3.69%Turnover RatioLossP/E (Static)26.36MShares18.93052wk High61.81P/B272.80MFloat Cap7.51052wk Low--Dividend TTM25.81MShs Float55.350Historical High--Div YieldTTM17.65%Amplitude4.410Historical Low10.540Avg Price1Lot Size
Avita Medical Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -28.75%-48.94M | 25.61%-8.08M | 19.61%-7.21M | -40.42%-12.78M | -129.96%-20.86M | -99.11%-38.01M | -216.15%-10.86M | -223.15%-8.97M | -159.51%-9.1M | 3.17%-9.07M |
| Net income from continuing operations | -74.80%-61.85M | -64.03%-11.59M | -86.01%-16.21M | -48.24%-15.39M | -102.36%-18.66M | -32.69%-35.38M | -31.98%-7.07M | -55.91%-8.71M | -65.85%-10.38M | 2.57%-9.22M |
| Operating gains losses | 104.70%402K | 108.73%753K | 1,074.29%822K | -22,800.00%-2.04M | 43,600.00%870K | -10,320.73%-8.55M | -24,050.00%-8.62M | 188.61%70K | 111.84%9K | -105.41%-2K |
| Depreciation and amortization | 78.16%1.13M | 118.72%409K | 89.02%310K | 39.73%204K | 50.37%203K | 11.27%632K | 43.85%187K | 18.84%164K | 6.57%146K | -17.18%135K |
| Other non cash items | -19.48%3.71M | -86.31%420K | 891.46%1.63M | 34.20%773K | 11.40%889K | 284.39%4.61M | 1,781.60%3.07M | -61.95%164K | 139.00%576K | 119.83%798K |
| Change In working capital | 28.84%-4.68M | -24,966.67%-746K | 181.27%2.36M | 84.68%-51K | -87.26%-6.25M | -449.67%-6.57M | -98.93%3K | -396.84%-2.91M | -133.43%-333K | 3.42%-3.34M |
| -Change in receivables | -26.24%-4.17M | 6.15%-1.43M | -835.58%-1.53M | -41.72%-1.71M | 165.08%505K | -235.43%-3.3M | -2,838.46%-1.53M | 263.78%208K | -1,601.41%-1.21M | -5.58%-776K |
| -Change in inventory | 41.51%-2.16M | 13.12%-1.12M | 121.83%306K | 225.30%312K | -120.03%-1.66M | -895.42%-3.69M | -411.11%-1.29M | -1,992.54%-1.4M | 12.32%-249K | -425.00%-754K |
| -Change in prepaid assets | 23.50%-345K | -44.71%888K | 127.81%490K | 145.93%141K | -15,633.33%-1.86M | -23.22%-451K | 400.75%1.61M | -4,662.16%-1.76M | -322.46%-307K | -82.09%12K |
| -Change in payables and accrued expense | 30.75%2.82M | -36.55%1.08M | 2,604.65%3.49M | -52.76%1.18M | -34.60%-2.93M | 38.74%2.16M | 0.65%1.7M | -89.43%129K | 80.53%2.5M | 20.59%-2.18M |
| -Change in other current assets | 62.77%-462K | 100.21%1K | -247.73%-130K | 65.71%-72K | 58.90%-261K | -36.98%-1.24M | -598.97%-484K | 116.42%88K | -29.63%-210K | -108.20%-635K |
| -Change in other current liabilities | -75.39%-784K | 17.74%-612K | -49.48%-571K | 166.88%424K | -101.90%-25K | 48.14%-447K | 54.10%-744K | -163.67%-382K | -1,212.28%-634K | 1,187.25%1.31M |
| -Change in other working capital | 4.68%425K | -39.11%450K | 46.23%310K | -42.79%-327K | 97.47%-8K | -45.14%406K | -22.37%739K | 390.41%212K | -231.88%-229K | -351.43%-316K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -28.75%-48.94M | 25.61%-8.08M | 19.61%-7.21M | -40.42%-12.78M | -129.96%-20.86M | -99.11%-38.01M | -216.15%-10.86M | -223.15%-8.97M | -159.51%-9.1M | 3.17%-9.07M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 2,225.02%37.36M | 104.31%2.47M | -66.02%7.39M | -32.30%12.43M | -19.81%15.07M | 108.31%1.61M | -1,714.57%-57.3M | 361.27%21.76M | 24.44%18.36M | 183.12%18.79M |
| Net PPE purchase and sale | -564.08%-9.17M | -444.59%-1.61M | -649.00%-3.76M | -786.96%-2.65M | -303.87%-1.15M | -205.53%-1.38M | -322.86%-296K | -382.69%-502K | -39.72%-299K | -343.75%-284K |
| Net intangibles purchase and sale | -145.45%-162K | 35.29%-22K | -460.00%-56K | 80.00%-1K | -388.24%-83K | 9.59%-66K | -70.00%-34K | 52.38%-10K | 75.00%-5K | -41.67%-17K |
| Net investment purchase and sale | 1,429.01%46.7M | 107.21%4.11M | -49.67%11.21M | -19.19%15.09M | -14.63%16.3M | 116.24%3.05M | -1,757.04%-56.97M | 371.49%22.27M | 24.53%18.67M | 184.74%19.09M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 2,225.02%37.36M | 104.31%2.47M | -66.02%7.39M | -32.30%12.43M | -19.81%15.07M | 108.31%1.61M | -1,714.57%-57.3M | 361.27%21.76M | 24.44%18.36M | 183.12%18.79M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -91.31%3.51M | -97.41%1.02M | 67.83%1.01M | 396.49%849K | 269.01%631K | 4,386.00%40.37M | 4,286.21%39.43M | 600K | 171K | 17,000.00%171K |
| Net issuance payments of debt | --0 | ---- | ---- | ---- | ---- | --38.76M | ---- | ---- | ---- | ---- |
| Proceeds from stock option exercised by employees | 117.62%3.51M | 52.39%1.02M | 67.83%1.01M | 396.49%849K | 269.01%631K | 79.11%1.61M | -25.47%670K | --600K | --171K | 17,000.00%171K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -91.31%3.51M | -97.41%1.02M | 67.83%1.01M | 396.49%849K | 269.01%631K | 4,386.00%40.37M | 4,286.21%39.43M | --600K | --171K | 17,000.00%171K |
| Net cash flow | ||||||||||
| Beginning cash position | 21.77%22.12M | -63.35%18.64M | -53.44%17.45M | -39.57%16.95M | 21.77%22.12M | -67.40%18.16M | 113.54%50.85M | 7.29%37.49M | 18.17%28.05M | -67.40%18.16M |
| Current changes in cash | -303.22%-8.07M | 84.03%-4.59M | -91.13%1.19M | -94.69%501K | -152.27%-5.17M | 110.58%3.97M | -404.57%-28.74M | 220.54%13.39M | -16.14%9.43M | 130.92%9.89M |
| Effect of exchange rate changes | --0 | --0 | --0 | --0 | --0 | 38.46%-16K | -102.27%-1K | 0.00%-18K | 104.35%2K | 116.67%1K |
| End cash Position | -36.48%14.05M | -36.48%14.05M | -63.35%18.64M | -53.44%17.45M | -39.57%16.95M | 21.77%22.12M | 21.77%22.12M | 113.54%50.85M | 7.29%37.49M | 18.17%28.05M |
| Free cash flow | -47.68%-58.27M | 13.20%-9.72M | -16.28%-11.03M | -64.09%-15.43M | -135.69%-22.09M | -101.16%-39.46M | -217.44%-11.19M | -226.88%-9.49M | -151.40%-9.41M | 0.76%-9.37M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Trending Stocks
Discussing
FOMC leaves rates unchanged, how will you adjust your portfolio?
FOMC left the target Federal Funds rate unchanged at at target of 4.25%-4.5%, how will you adjust your portfolio?
Moo Live
Jan 30 03:25
FOMC Press Conference, January 29, 2025